High TPI1 expression is often inversely related to clinical outcomes in lung adenocarcinoma, laryngeal squamous cell carcinoma, breast cancer, Ewing’s sarcoma, and cholangiocarcinoma [54,55,56,57,58]. This evidence concerns the gene TPI1 and breast carcinoma.